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Upon activation mast cells (MCs) secrete numerous inflammatory compounds stored in
their cytoplasmic secretory granules by a process called anaphylactic degranulation, which
is responsible for type I hypersensitivity responses. Prestored mediators include histamine
and MC proteases but also some cytokines and growth factors making them available
within minutes for a maximal biological effect. Degranulation is followed by the de novo
synthesis of lipid mediators such as prostaglandins and leukotrienes as well as a vast array
of cytokines, chemokines, and growth factors, which are responsible for late phase inflam-
matory responses. While lipid mediators diffuse freely out of the cell through lipid bilayers,
both anaphylactic degranulation and secretion of cytokines, chemokines, and growth fac-
tors depends on highly regulated vesicular trafficking steps that occur along the secretory
pathway starting with the translocation of proteins to the endoplasmic reticulum. Vesicular
trafficking in MCs also intersects with endocytic routes, notably to form specialized cyto-
plasmic granules called secretory lysosomes. Some of the mediators like histamine reach
granules via specific vesicular monoamine transporters directly from the cytoplasm. In this
review, we try to summarize the available data on granule biogenesis and signaling events
that coordinate the complex steps that lead to the release of the inflammatory mediators
from the various vesicular carriers in MCs.
Keywords: mast cells, signaling, vesicular trafficking, secretion, inflammation
INTRODUCTION
Mast Cells (MCs) are tissue cells that are well known effectors
in IgE-mediated allergic or anti-parasitic responses, but research
in the last two decades has revealed that they are also impor-
tant participants in innate immunity and inflammation (1, 2).
One of their prime functions is to release a large array of inflam-
matory mediators, which mediate tissue responses, participate in
immunoregulatory and inflammatory processes as well as tissue
remodeling (2–5). These mediators include compounds prestored
in a release-ready form in their cytoplasmic secretory granules
(SGs) such as histamine and MC specific proteases. MC also
secrete newly synthesized lipid mediators such as leukotrienes or
prostaglandines or a variety of cytokines, chemokines, and growth
factors (3, 6). While synthesized lipid compounds freely diffuse
across the membrane, the release of protein products depends on
vesicular carriers and membrane fusion (7, 8).
Study of the biologic function and involved signaling pathways
engaged by various membrane receptors has evidenced that MC
can release either their full array of mediators or just some of them
under particular conditions of stimulation (9). For example, while
stimulation through the IgE Fc receptor (FcεRI) generally leads
to a full response, stimulation through Toll-like receptor 2 and 4
(TLR2 and TLR4) or through some cytokine receptors induces the
selective release of newly synthesized chemokines and cytokines
in the absence of degranulation (9). The release characteristics
also depend on the strength of stimulus as, for example, after
weak stimulation (low antigen concentration in case of FcεRI) the
release of chemokines over cytokines is favored (10). This is due
to the engagement of different signaling pathways that at least in
part imply engagement of distinct Src-related kinases (11).
Research in recent years on secretory mechanisms after stim-
ulation has mostly focused on the degranulation process that
concerns the release of mediators stored in cytoplasmic gran-
ules, which amongst many other compounds includes also certain
cytokines (4). At present, little is known on the vesicular traf-
ficking of newly synthesized cytokines and chemokines and its
positive and/or negative regulation. Yet, it is clear that like secre-
tion from cytoplasmic granules the release of newly synthesized
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FIGURE 1 | Model for the secretory pathways in MC. Newly synthesized
proteins destined for secretion enter the secretory pathway at the rough
ER. After passage through the Golgi where posttranslational modifications
occur, they reach the trans-Golgi network (TGN), which functions as a
sorting hub depending on various structural motifs. For example,
GPI-anchored or N -and O-glycosylated proteins enter the constitutive
secretory pathway for trafficking to the cell surface. Proteins destined for
the endosomal–lysosomal pathway are modified by Mannose-6 phosphate
(MP6) for recognition by the Mannose-6-phosphate receptor that via an
acidic cluster/dileucine motif is delivered to the early endosome (EE).
Together with endocytosed proteins destined for degradation they are
further sorted to late endosomes (LE) forming multivesicular structures and
then fuse with lysosomes (Lys) via a VAMP-7 and Rab7-dependent pathway.
Some proteins, like for example, newly synthesized TNF may be sorted into
vesicles to reach the endocytic recycling compartment (ERC) from where it
could be secreted. The ERC may serve as an additional sorting hub for the
exocytosis and recycling of proteins via retrograde pathways (not shown in
this figure). The cytoplasmic SG, which contain proteins destined for the
regulated secretory pathway for release upon stimulation in MC and other
hematopoietic cells are so-called mixed type organelles or secretory
lysosomes carrying features of endosomes and lysosomes. Proteins
destined for SG may leave the TGN at sites where larger protein aggregates
are formed possibly via association to highly negatively charged
proteoglycans. The immature SG formed may then rapidly fuse with carriers
(type I SG) containing small intraluminal vesicles derived from the early
endosome via a Rab5 and VAMP-8 dependent mechanism to form type II
SG. Some inflammatory mediators like histamine incorporates into SG via
specific vesicular monoamine transporters (VMAT). SG then undergo a
maturation process, which generates mature type III SG by the retrieving
cargo of missorted proteins and intraluminal vesicles to the ERC.
Pre-formed inflammatory mediators can then be released via several types
of fusion processes including transient kiss-and-run fusion, piecemeal
degranulation, or multigranular/compound exocytosis, which involves full
fusion and collapse of SG. It is possible that during stimulation all types of
granules (type I, II, and III) are fusion competent as suggested by the fact
that cultured cells with less mature granules can be stimulated for release.
chemokines, cytokines, and growth factors must be tightly regu-
lated to ensure an appropriate biological response. Here, we review
some of the important aspects of the vesicular trafficking mech-
anisms and their involvement in MC cytokine and chemokine
secretion.
SECRETORY PATHWAYS IN MC
In MC, like in any other cell type, the secretory pathway (Figure 1)
starts with the translocation of nascent signal-peptide contain-
ing proteins at the rough endoplasmic reticulum (ER) after
recognition by the cytosolic signal-recognition particle (SRP)
ribonucleoprotein complex, which binds to the ER-localized SRP-
receptor (12). From the ER, the proteins sequentially travel
through the Golgi stacks via a still not completely understood
process involving either Golgi cisternal maturation or vesicular
transport carriers (13). While passing the Golgi stacks posttrans-
lational modifications occurs, such as for example, glycosylation,
and proteins finally reach the Trans-Golgi network (TGN). The
TGN functions as a sorting hub for protein trafficking (14–16).
By default, via the constitutive secretory pathway, glycosylated or
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glycosylphosphatidylinositol (GPI)-anchored proteins are deliv-
ered to the plasma-membrane (PM) via tubular–vesicular carriers
that bud off from the ER by a well regulated process involving
motor proteins and fission processes and then fuse with the PM
(16). However, in the presence of specific sorting signals (sorting by
exit) proteins may be routed to other intracellular compartments.
For example, within the Golgi apparatus, lysosomal hydrolases
acquire a mannose-6-phosphate (M6P) moiety (17). M6P is then
recognized by the M6P receptor (M6PR) at the TGN. An acidic
cluster/dileucine motif in the cytoplasmic tail of the M6PRs then
serves as a sorting signal for specific adaptor proteins (such as
AP-1) allowing packing into clathrin-coated transport vesicles tar-
geting them to early endosomes (16). Within early endosomes, the
acidic environment of the endosomal lumen releases hydrolases
from the M6PR. After maturation into late endosomes a process
that is accompanied by the generation of intraluminal vesicles via
the endosomal sorting complexes required for transport (ESCRT)
machinery (18) the late endosomes fuse with existing lysosomes,
where hydrolases and other proteins like proteases accumulate and
get activated to degrade proteins.
Another important pathway is the regulated secretory pathway.
Specialized secretory cells such as endocrine, neuronal, exocrine,
but also hematopoietic cells have the capacity of regulated secre-
tion liberating secretory cargo stored in cytoplasmic granules
following arrival of a stimulus (14). While endocrine, neuronal,
and exocrine cells are known to form specialized SGs, cells from
the hematopoietic lineage, but also some other cells such as
melanocytes, possess mixed type organelles often called secretory
lysosomes due to their close connection between the endocytic
and exocytic pathway (19). They are characterized by the pres-
ence of lysosomal enzymes as well as markers of lysosomal origin
such as CD63/LAMP-3, and LIMP IV/5G10 antigen (17). They
often are also altered in patients with lysosomal storage diseases
carrying mutations in a variety of genes involved in lysosome
biogenesis (19).
The biogenesis of SG has been well worked out in neuroen-
docrine cells (15). In these cells, proteins targeted to the regulated
secretory pathway become associated with specialized regions
of the TGN forming larger aggregates that eventually associate
with other soluble or membrane-localized cargo protein (sort-
ing by entry) (14). After budding immature SG are formed that,
via a series of homotypic fusion events, give rise to mature SG.
This process is coupled to the removal of non-secretory mis-
sorted cargo via clathrin-coated vesicles (sorting by retention)
and condensation, the latter being at least partially favored by
the acidic environment in the granules maintained actively by
proton pumps (5). In contrast to the well-characterized gran-
ule biogenesis in neuroendocrine cells, the biogenesis of secretory
lysosomes is less clear. While melanosomes, for example, seem to
derive from early or sorting endosomes with few small intralu-
minal vesicles (20), granules from lytic T cells are likely modified
lysosomes containing a ring of multivesicular bodies, which derive
from the fusion of late endosomes, surrounding a dense core
that further matures upon T cell activation (19–21). The dense
cores might derive, like for conventional SG, from the TGN. It is
possible that proteoglycans may play an important role by their
capacity to selectively aggregate and attract regulatory secretory
proteins via charged interaction thereby serving as a nucleation
point for sorting (22). In favor, experiments carried out with
proteoglycan deficient hematopoietic cells, including MC, all show
serious defects in granule biogenesis, protease content, and matu-
ration (5). Additional studies showed that SG containing at least
some of the granule proteases and mediators could still be formed
even in the absence of proteoglycans leaving open the possibility of
proteoglycan-independent formation of immature SG (23). How-
ever, the fact that all these SGs are morphologically altered lacking
an electron dense core and crucial enzymes favor an important
role of proteoglycans in physiological SG formation.
In MC, electron microscopy studies (24) have allowed to define
three types of SGs: (1) type I SG likely representing matured endo-
somal/lysosomal organelles with numerous intraluminal vesicles
that are rapidly accessible to endocytic tracers, (2) type II SG,which
like in cytotoxic T cells contain a dense protein core surrounded
by multivesicular bodies; these granules are also rapidly accessi-
ble to endocytic tracers, and (3) type III SG containing essentially
electron dense material no more accessible to endocytic tracers.
Likely, type III SGs are generated by a maturation process that
may involve Synaptotagmin III (SytIII) regulating recycling and
delivery of cargo to the endocytic recycling compartment (ERC)
during granule maturation (25). This suggests that the ERC could
be an important intermediate in granule recycling and matura-
tion. The nature of the involved endocytic compartment is also
not completely clear, but recent data have indicated an important
role of the early endosomal marker Rab5 and VAMP-8 in granule
size determination (26). This suggests that multivesicular bod-
ies or type I SG may not derive from late endosomes but could
directly form at the early endosome and fuse with Golgi-derived
specialized SGs in homotypic fusion events (26). A possible role
of SytIX in this process has been proposed as it excludes proteins
destined for recycling to reach the SG (27). However, the fact that
in human MC VAMP-7 serves as a soluble N -ethylmaleimide-
sensitive factor attachment protein receptor (SNARE) for release
of SG may suggest that genuine late endosomes may also take
part in the generation of SG (28). Granule maturation is a long
process that can take several months in MC, as indicated by data
(29) showing that MC SG get gradually enriched with incoming
cargo such as proteoglycans, MC proteases, but also histamine
and serotonin, the latter of which being transported via vesicular
monoamine transporter (VMAT) systems directly from the cyto-
plasm (5). Interestingly, these positively charged molecules also
contribute to granule homeostasis as in their absence SG matu-
ration is affected as shown for histamine and MC proteases (5,
30). In addition to these classical sorting pathways, the ERC, ini-
tially characterized for its role in the slow pathway of Transferrin
recycling, has also gained attention as a new sorting hub actively
sorting cytokines for release as demonstrated in macrophages (31).
ANAPHYLACTIC DEGRANULATION
PRESTORED INFLAMMATORY MEDIATORS
MC are the effector cells of type I hypersensitivity reactions, which
involves the release within a few minutes of cytoplasmic gran-
ular content into the surroundings after stimulation, a process
often called anaphylactic degranulation (32). A potent stimulus
for degranulation is the crosslinking of IgE bound to FcεRI by
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multivalent antigens or allergens (3). Indeed, one distinctive fea-
tures of MC is that they contain numerous SGs in their cytoplasm
(32, 33). These granules are filled with different inflammatory
compounds, many of which are bound to a highly charged anionic
gel matrix composed of proteoglycans such as heparin or chon-
droitin sulfate, which differ among the different MC types and
species (34). The presence of these proteoglycans attributes the
specific staining properties of MC with cationic dyes such as tolu-
idine blue enabling the classical metachromatic staining of MC
in tissues, which have led to the discovery of these cells by Paul
Ehrlich in the nineteenth century (35). Well-known mediators
bound to these proteoglycans are cationic amines such as hista-
mine or serotonin, but also proteases such as tryptase, chymase,
and carboxypeptidase [for a complete review see for example (4,
36)]. The formation of such a gel matrix allows their tight pack-
aging and is thermodynamically advantageous avoiding osmotic
work (37).
When MCs are stimulated, up to 100% of granular content can
be released in a single stimulation event within minutes enabling a
maximal biological effect in its immediate vicinity, but also often
with systemic effects as for example,occurring during a generalized
anaphylactic shock (38, 39). This degranulation is made possible
by a special type of exocytosis mechanism often called compound
exocytosis involving the fusion of PM proximal granules with the
PM followed by the sequential fusion with granules lying deeper in
the cytoplasm (Figure 1). Although such sequential fusion events
have been shown by electron microscopy studies (33), a multi-
granular fusion mode that leads to the fusion of large intracellular
fused granules with the PM has often also been observed (40).
Degranulation involves the extrusion of the whole condensed gel
matrix, which is accompanied by a drastic swelling due to their
hydration (41). The change in pH after release from the acidic
milieu in the granule to the neutral pH in tissues allows the dis-
sociation of cationic inflammatory mediators such as histamine
and MC proteases (5). In addition to this anaphylactic degranu-
lation mechanism, granular content can also be released in small
portions by a mechanism called piecemeal degranulation (PMD),
characterized by the gradual emptying of MC SG over much longer
periods of time, but also kiss-and-run fusion involving only a short
opening and contact with the external environment (see below).
While it was thought initially that cytokines are released only
after new synthesis, in groundbreaking discoveries, Galli and
coworkers (42) found that MC in addition to releasing newly syn-
thesized TNF were able to store TNF in SG from where it could be
released through anaphylactic degranulation. In particular, highly
differentiated tissue MC such as peritoneal MC in mice were found
to contain substantial amounts of TNF in their SG, while this was
less the case in cultured cells. In fact, in some cultured MC lines,
such as for example PT18 or RBL-2H3 (42, 43), no prestored TNF
is detectable while this amount seems variable for other lines or
primary cultured MC such as BMMC. Our own experiments in
BMMC show that they contain detectable TNF that colocalizes
with SG markers (Figure 2), but this concerns only a small frac-
tion of cells, while other cells clearly express only classical granule
markers such as serotonin or proteases. It is therefore possible
that TNF can accumulate only in mature granules. As a possi-
ble mechanism a specific sorting signal based on N-glycosylation
FIGURE 2 | Localization of TNF in SG in cultured BMMC. Colocalization
of TNF (blue) with the SG markers serotonin (red) were analyzed in
non-stimulated BMMC using confocal microscopy. Representative single
optical sections and overlay (Merge) and the DIC images are shown. Note
that in a single field only few cells show such TNF SG granular staining.
transporting TNF to the endosomal system was proposed (44). In
human MC, where TNF is not glycosylated, TNF became enriched
in SG after transient exposure on the PM and re-endocytosis (45).
Besides TNF, a series of other cytokines including for example, IL-
4, IL-5, IL-13, and vascular endothelial growth factor (VEGF) have
been reported to be prestored in MC SG (4). Prestored cytokines
have also be found in other cells of hematopoietic origin including
eosinophils, platelets, and neutrophils (46–49).
EARLY SIGNALING PATHWAYS IN ANAPHYLACTIC DEGRANULATION
Anaphylactic degranulation can be induced via immunoreceptors,
the FcεRI as a prototype (3), but MC can also be stimulated via
IgG receptors under certain conditions (50). Furthermore, MCs
express a whole variety of other receptors that can promote ana-
phylactic degranulation in particular certain G protein coupled
receptors (GPCRs) such as receptors for complement peptides
C5a and C3a, receptors for neuropeptides or receptor for cer-
tain inflammatory peptides such as for example endothelin (4).
Independent of the receptor type, they all can induce a calcium
signal and the activation of protein kinase C (PKC), in particu-
lar PKCα/β, which are necessary for anaphylactic degranulation
to occur (3, 51). Signals which do not induce a substantial cal-
cium response, such as for examples those generated via LPS
and Toll-like receptors, although inducing the secretion of newly
synthesized cytokines or chemokines do not induce anaphylactic
degranulation.
Some recent reviews describe in detail the main molecular
events following FcεRI crosslinking in MC (6, 51). Briefly, after
antigen-dependent activation of FcεRI receptor, Src family kinases
Lyn and Fyn are activated causing phosphorylation of FcεRIβ and
FcεRIγ chains ITAMs (Figure 4). Receptor activation opens mem-
brane calcium channels causing a receptor-operated calcium entry
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FIGURE 3 | Late signaling events in the anaphylactic degranulation.
Aggregation of IgE bound to FcεRI leads to the generation of elevated levels
of intracellular Ca2+ and the activation of PKC. In parallel, it also leads to the
activation of PLD and IκB Kinase (IKK). Together they trigger anaphylactic
degranulation, which involves SG–SG and SG–PM fusion events. Fusion is
mediated by SNARE proteins that lie on opposing membrane. The formation
of a stable well-characterized trans-SNARE complex in MC comprises the
v-SNARES VAMP-8 that pairs with the two t-SNAREs, Syntaxin 4, and
SNAP-23. During SG–SG fusion SNAP-23 relocates to the cytoplasm, which
may be characteristic for the compound/multigranular fusion mode in MC. The
SG-localized t-SNARE Syntaxin 3 may be specifically implicated in SG–SG
fusion events and in a manner opposite to SNAP-23 translocates to the PM
upon activation. Other v-SNAREs like VAMP-2 and VAMP-7 might also play a
role in anaphylactic degranulation, which may indicate redundance or
heterogeneity of the MC secretory compartment. The formation of SNARE
complexes is modulated by multiple accessories proteins such as Munc18-2,
Synaptotagmin II, Complexin, SCAMP, Doc2α, Rab27A and B, and Munc13-4
that allow to connect the fusion machinery to early signaling events to relieve
existing fusion clamps and to coordinate the docking, thethering, and fusion
events as well as the connection to cytoskeletal reorganization and transport
mechanisms. Fusion is closely coupled to endocytosis of membrane lipids
and proteins. The individual SNARE proteins are reconstituted by an
energy-requiring step, which is mediated by the NSF ATPase via the α-SNAP
adaptor protein.
(ROCE). Lyn kinase activation leads to the recruitment and activa-
tion of Syk kinase. Syk, in turn, phosphorylates the adapters LAT,
SLP76, Gab2, and NTAL, among others. Those adapters participate
in the assembly of large signaling complexes that include molecules
such as Bruton’s tyrosine kinase (BTK), which activates phospho-
lipase Cγ (PLCγ) cooperatively with Syk. PLCγ activation induces
diacylglycerol (DAG) production and inositol-1,4,5-trisphosphate
(InsP3)-induced Ca2+ mobilization. Emptiness of intracellular
calcium stores leads to the activation of a store-activated calcium
entry (SOCE) to replenish internal stores. DAG and Ca2+ induce
the activation of classical isoforms of PKC, PKCα, andβ. On a com-
plementary pathway, Fyn kinase phosphorylates Gab2 leading to
the activation of phosphoinositide 3 kinase (PI3K). This results
in activation of the PI3K-dependent protein kinase I (PDK1) and
PKCδ. PI3K activation induces Phospholipase D (PLD) and Akt
activation, the latter favoring MC survival and mTOR activation
(51, 52). The Lyn pathway is essential for Ca2+ signaling, whereas
the Fyn-dependent pathway is required for degranulation and
maintenance of Ca2+ mobilization (53).
LATE SIGNALING EVENTS IN ANAPHYLACTIC DEGRANULATION
In addition to calcium and PKC, many different actors that
are involved in the control of fusion during degranulation
have been recently described (Figure 3). These include the
highly conserved SNARE membrane fusion proteins (54–57).
SNAREs can be divided into vesicular (v-SNARE) and tar-
get (t-SNAREs) localized, respectively, on opposing donor and
acceptor membranes. They contain in their primary struc-
ture and about 60 aa α-helical SNARE motif, which upon
arrival of the appropriate stimulus, can zipper to form a tight
tetrameric trans-SNARE complex (composed of one v-SNARE
and either two or three t-SNAREs, depending on the num-
ber of contained SNARE motifs) that drives the merger of
lipid bilayers. After fusion SNAREs are disassembled under
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energy consumption by the ATPase N -ethylmaleimide-sensitive
factor (NSF), which becomes recruited to the SNARE com-
plex via an adaptor called Soluble NSF Attachment Pro-
tein (SNAP).
While, SNARE complex formation and fusion can be reconsti-
tuted into liposomes in the absence of any additional protein (58),
the process is extremely slow indicating additional control mech-
anisms. In living cells, numerous accessory proteins have been
found to regulate membrane fusion including Sec1/Munc18 (SM)-
, Munc13-, Rab-, complexin-, and Synaptotagmin (Syt)-family
members (56, 59). Together, they are responsible for the priming,
tethering, and docking to ensure specificity and efficiency of the
fusion process. They also allow to connect the fusion machinery to
cell stimulation relieving existing fusion clamps. Many were ini-
tially characterized in neuronal secretion at the synapse. Although,
in general, the basic principles described may apply to secretion in
other cells, differences clearly exist. In particular, vesicular release
at the synapse is set up for an extremely fast (within millisec-
onds) release followed by a fast recycling process at specific active
zones requiring likely additional proteins such as voltage-gated
calcium channels or proteins involved in vesicle docking such as
RIM (59). In other cells, such as MC the process is generally more
dynamic and might require a more extensive crosstalk with the
cytoskeleton for transport mechanisms that does not occur at spe-
cific active zones. Furthermore, as mentioned above, they involve
also granule–granule fusion events to obtain a maximal release
within the scale of a few minutes. Some of the differences are
summarized in Table 1.
Several of the early studies in MC provided convincing evidence
that, like in neurons, fusion implies SNARE proteins (60–63).
Table 1 | Comparison of exocytosis in mast cells and neurons.
Parameter Mast cells Neurons
Granules Secretory lysosomes Specialized secretory
granules
Granule size 300–1000 nm 50 nm
Granule number Up to 1000/cell 200–500/nerve terminal
Ca2+ requirements 1µM 200µM
PKC requirement Yes No
Time frame of
exocytosis
Minutes Milliseconds
Recycling time Long (hours to days) Very short (seconds to
minutes)
Site of release Multidirectionala Active zone
Release
characteristics
One single release, up
to 100% of total
granular content; multi-
granular/compound
mode
Multiple release one
granule per fusion event
aNote that under specific local conditions of stimulation, mast cells are able to
deliver SG content within specific zones.
Work from several laboratories has allowed to define a cen-
tral SNARE complex composed of the PM-localized t-SNAREs
SNAP-23 and Syntaxin 4 as well as the vesicular localized VAMP-8
(64–66). Interestingly, SNAP-23 was found to relocate to the cyto-
plasm in degranulation channels following activation, which could
be a specific characteristic of the compound/multigranular mode
of fusion as it enables granule lying deeper inside to get access
to this PM SNARE (60). Furthermore, the implication of VAMP-
8, which was initially described as an endosomal SNARE called
endobrevin (67) was a clear indication for the close connection of
the granular compartment with the endosomal/lysosomal system.
In addition to these three SNAREs other possible SNAREs impli-
cated include Syntaxin 3,VAMP-7, and VAMP-2 (28, 66, 68–70). In
murine, but not in human MC (71), Syntaxin 3 is localized to SG
and translocates to the PM, which might in a manner analogous
to SNAP-23 be a characteristics of the compound/multigranular
mode of fusion (70). However, the association with other SNARE
proteins like Vti1b involved in vesicular fusion events is also pos-
sible (55). The fact that several types of SNARE complexes are
implicated in membrane fusion in MC could be in agreement
with the heterogeneity of the secretory compartment.
In addition to cognate SNARE proteins anaphylactic degranu-
lation is regulated by an array of additional factors and signaling
events. They include small GTPases known to regulate and coordi-
nate discrete steps along the vesicular trafficking (72). A functional
screen comprising 44 different Rab GTPases showed that many
Rabs can affect either antigen and/or ionomycin/PMA triggered
anaphylactic degranulation (73). The best characterized Rabs are
the Rab27A and B isoforms. These studies indicate that while
Rab27A may play a role in regulating the cortical actin disassem-
bly limiting access of SG to the membrane, the role of Rab27B or
the combined action of Rab27A and B facilitates degranulation
by switching granules from microtubule-dependent movement to
F-actin-dependent docking (74, 75). Indeed, degranulation is also
accompanied by important remodeling of the actin cytoskeleton,
which may favor the access to the PM (3). The docking step may
imply another important factor, Munc13-4, that interacts with
Rab27. Indeed, it was shown in MC that the interaction between
both partners was required to correctly tether SGs at the PM and
to prime them for fusion (75–77). Controversial data have been
obtained with regard to the role of Rab3 isoforms. While initial
data showed a potential role of Rab3A (78), we found that this
isoform was not targeted to membranes in RBL MC and that its
overexpression had no effect (79, 80). Rab3D, on the contrary, was
SG-localized (81). Overexpression of wild-type and a constitu-
tively active Rab3D mutant affected exocytosis (79). However, this
was not confirmed in MC obtained from Rab3D knock-out ani-
mals although compensatory mechanisms by other Rab3 isoforms
have not been examined (82).
Sec1/Munc18 protein family members are another type of
fusion accessory proteins. They include three Munc18 isoforms
implicated in exocytosis and some other family members involved
in intracellular trafficking steps (56). Initial analysis of the neu-
ronal isoform Munc18-1 suggested that it might be a negative
regulator of fusion by its capacity to bind to particular syn-
taxin SNAREs preventing the binding of cognate SNARE partners.
However, analysis of knock-out mice showed that its absence
Frontiers in Immunology | Molecular Innate Immunity September 2014 | Volume 5 | Article 453 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blank et al. Mast cell vesicular trafficking and secretion
completely blunted synaptic transmission advocating a positive
regulatory function (56). Later on this was explained functionally
by data showing that during exocytosis Munc18-1 switches its
binding mode to bind the assembled SNARE complex thereby
aiding the fusion process probably by electrostatic interactions
with the membrane for fusion pore expansion (56, 83, 84). MC do
not express protein of the neuronal isoform Munc18-1 but express
ubiquitious Munc18-2 and Munc18-3 (85, 86) and Munc18-1 does
not seem to play a role (87). No functional data have been obtained
for Munc18-3, but several studies by different authors have clearly
shown that the Syntaxin 3 binding protein Munc18-2 acts as a
positive regulator of fusion as in its absence exocytosis is compro-
mised in MC (70, 88, 89) but also in other hematopoietic cells (90).
Further functional studies indicated that knock-down of both
Syntaxin 3 and Munc18-2 yielded additive inhibitory effects on
exocytosis suggesting that Munc18-2 besides fusion might regulate
additional steps (70). Video imaging of SG movement indicated
that Munc18-2 affected SG translocation to the membrane, likely
through its dynamic interactions with the microtubule cytoskele-
ton (70). Munc18-2 may also represent a possible target for the
action of protein PKC (8, 91). As data in chromaffin cells already
suggested a docking effect (92), it may be possible that SG dock-
ing may not be static, but rather a dynamic process that needs
to be maintained via cytoskeletal interactions. In agreement, the
neuronal Munc18-1 isoform has also be found to bind to the
Kinesin-1 adaptor protein, fasciculation, and elongation protein
zeta-1 (FEZ1) (93).
Secretory carrier membrane proteins (SCAMPs), a family of
ubiquitous membrane proteins of transport vesicles (94) has
also been shown to regulate fusion. These tetraspanins contain
a short conserved segment (E-peptide) between the second and
third transmembrane domain. MCs express three SCAMP iso-
forms, with SCAMP1 and SCAMP2 being most highly expressed.
Introduction of the E-peptide interfered with degranulation in
permeabilized MC (95, 96). SCAMPs may act at the final fusion
step in agreement with data showing that genetic deficiency of
SCAMP2 causes an apparent defect in forming stable fusion pores
that may depend on Arf6-stimulated PLD activity (94). PLD was
indeed proposed as an effector in MC exocytosis (97).
Several effectors molecules have been described that connect
the fusion apparatus to Ca2+ signaling. This includes Syt family
proteins, which are single transmembrane proteins with tandem
calcium-binding C2 domains (termed C2A and C2B). Calcium-
binding promotes oligomerization and membrane phospholipid-
binding as well as the interaction with the SNARE complex, allow-
ing the formation of a quaternary SNARE-Syt-Ca2+-phospholipid
(SSCAP) complex driving of lipid bilayer mixing (98). While, neu-
ronal expressed SytI was initially characterized as a possible sensor
(99), recent studies in knock-out mice provided a clear evidence
for the role of SG-localized SytII as the relevant Ca2+ sensor in
MC (100). MC deficient in SytII showed a severe defect in both
lysosomal β-hexosaminidase and histamine release and conferred
to these mice a strongly decreased passive cutaneous anaphylaxis
reaction (100). Although in addition to SytII, other Syt isoforms
are expressed in MC, they do not seem to be directly involved in the
fusion process but rather may regulate other intracellular traffick-
ing steps (7). SytII may act in concert with ComplexinII (101, 102),
a protein that binds to assembled SNARE complexes and that has
been described in neurons to function as a fusion clamp. However,
data from knock-out mice also support a positive action on exocy-
tosis involving sequences adjacent to the SNARE-complex-binding
domain. It seems that its interaction with the SNARE complex
generates a metastable state that serves as a substrate for Syt follow-
ing Ca2+-influx with the induced rearrangement and cooperative
interactions promoting fusion (56, 59).
In addition to Syt, Doc2 adaptors also contain tandem calcium-
binding C2A and C2B domains the former of which exhibiting
calcium-dependent phospholipid-binding activity thought to be
important for regulated exocytosis through possible interactions
with Munc13 isoforms as well as partly assembled SNARE com-
plexes (103). MCs express the Doc2α isoform thought to be
neuronal-specific, while the ubiquitous Doc2β isoform was not
expressed (104). Doc2α-deficient MC showed a marked defect in
degranulation and formed a tripartite complex with Munc13-4
and Rab27 suggesting that it could play a role in vesicle priming
(104). Another possible Ca2+-dependent process involves a kinase
activity called Rak3D (from Rab3D-associated kinase) that was
associated with Rab3D (105). Rak3D phosphorylated Syntaxin 4,
but not Syntaxin 2 and 3 in its N-terminus, which prevented bind-
ing of the SNARE partner SNAP-23 suggesting that it could act as a
fusion block. In agreement, the association with Rab3D decreased
upon stimulation in a calcium-dependent manner. While phos-
phorylation of Syntaxin 4 was fusion inhibiting, phosphorylation
of the other t-SNARE protein SNAP-23 rather seemed to be fusion
promoting. This involved IκB kinase (IKK) also known to regulate
the phosphorylation of IκB, which induces nuclear transloca-
tion of the NF-κB transcription factor (106). Indeed, in activated
MC IKK phosphorylated a small fraction (~10%) of SNAP-23 on
Ser95/Ser120 within its cysteine-rich linker region. In the absence
of IKK, degranulation and anaphylactic responses were impaired.
This was associated with decreased SNARE complex formation
indicating a role for SNAP-23 phosphorylation in fusion.
OTHER FORMS OF DEGRANULATION
PIECEMEAL DEGRANULATION
Piecemeal degranulation is a mode of exocytosis characterized
by loss of granule content in the absence of clearly observable
granule–granule or granule–PM fusion events. PM is associated
with the generation of small vesicles ranging from 30 to 150 nm
budding from large SGs (107, 108) (Figure 1). Empty spaces of lost
secretory particles are recognizable inside the SG, without evidence
for changes in the size of the granule membrane. The mechanism
behind PMD is known as the “shuttling vesicle” hypothesis (109).
According to this, the transport of granule constituents out the
cell is mediated by vesicles shuttling from the granule compart-
ment to the PM. Electronic microscopy has shown, in fact, that
vesicular transport granule content is associated with this type
of secretion (110). Thus, an outwarding flow of cytoplasmic vesi-
cles loaded with granule materials effects granule depletion during
PMD. Vesicles containing part of the granule content buds from
the granule membrane and move through the cytoplasm and fuse
with the PM, leading to content discharge. In a closely coupled
inward flow, endocytotic vesicles are retrieved from the PM and
traverse the cytoplasm to fuse with granules. If the rate and amount
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of vesicular traffic are balanced, granules and PM will maintain
constant size. The most important characteristic of PMD is the
fact that it seems to be modulated in different steps and by dif-
ferent stimulants. Strongly enhanced PMD was observed in mice
overexpressing IL-4 resulting in eyelid lesions and enhanced fibro-
sis (111) or in human MC after stimulation with IL-1 (112). PMD
has been studied in a number of different immune cells (47) but
also enteroendocrine cells of the gastrointestinal tract, chromaf-
fin cells of the adrenal medulla and chief cells of the parathyroid
gland (108).
Alternatively to the shuttling vesicle hypothesis, PMD could
also be the results of kiss-and-run fusion, which also result in
partial vesicle emptying (see below).
KISS-AND-RUN EXOCYTOSIS
Kiss-and-run exocytosis refers to a special type of secretion in
which a fusion pore opens and closes during vesicle fusion with
the PM, allowing the release of some amount of granule con-
tent without full vesicle collapse (113). Kiss-and-run exocytosis
(also known as “cavicapture”) has been reported in PC12 cells
(114), chromaffin cells (115), and insulin secreting pancreatic
beta-cells (MIN6)-cells (116). In MC, initial classical patch clamp
studies led to the observation of capacitance changes in the PM
due to exocytosis of individual granule contents after GTP addi-
tion and, interestingly, this event seemed to be independent of
Ca2+mobilization (117). Later, a series of experiments using peri-
toneal MC from beige mice demonstrated “capacitance flickering”
after intracellular administration of GTPγS, suggesting rapid and
reversible steps in membrane fusion due to the opening and clos-
ing of a fusion pore, narrow enough to retard the escape of some
molecules (118) but leading to the leakage of some soluble gran-
ule components. Besides these electrophysiological measurements
kiss-and-run fusion in MC could also be observed directly in mul-
ticolor multiphoton fluorescence microscopy in histamine loaded
cells through the pH cycling that occurs after a release event.
In these studies using a tumor MC line the authors found that
kiss-and-run fusion occurs actually very frequently accounting for
about one-third of all fusion events in MC (119).
The choice between kiss-and-run and full fusion of vesicles
may depend on several different mechanisms. One vision is that
kiss-and-run fusion occurs when the threshold for full fusion is
not reached. The threshold would be determined by the inter-
play between the regenerative recruitment of SNARE-mediated
force and some kind of restraining force that counterbalance
vesicle fusion. According to this “restraining force hypothesis”
cytoskeleton-dependent restraining barriers exist that counterbal-
ance SNARE-driven fusion mechanisms (113). Studies in neurons
have shown that the relative incidence of kiss-and-run fusion is
strongly regulated by key factors such as intracellular calcium accu-
mulation, impulse frequency, and a previous history of activity.
Calcium is important to switch the kiss-and-run mode of secre-
tion to the full fusion events. High calcium shifts the mechanism
from kiss-and-run to complete fusion (120). Furthermore, some
lines of evidence suggest that the number of SNARE complexes
might also be important in the balance between kiss-and-run and
full fusion. In reconstituted systems (121), it has been calculated,
for example, that one SNARE complex is sufficient for the bilayer
fusion observed in kiss-and-run and three of those complexes
are needed to prevent the nascent fusion pore from reclosing (a
phenomenon needed in full fusion exocytosis). Also, the stability
of the fusion pore can be altered by accessory proteins of SNARE
function, including Syt (122), complexin (123), and Gβγ (124).
ENDOCYTOSIS–EXOCYTOSIS COUPLING
Regardless of the mechanism of exocytosis, the incorporation of
membrane during exocytosis has to be closely coupled to endo-
cytosis to retrieve the additionally inserted membrane. Several
modes of endocytosis have been characterized (125). They include
endocytosis after (i) full-collapse fusion, in which collapsed vesi-
cles are retrieved by classical endocytosis involving membrane
invagination and vesicle reformation, (ii) kiss-and-run fusion, in
which the fusion pore just opens and closes without any signif-
icant membrane traffic, and (iii) after compound/multivesicular
exocytosis one can also observe bulk endocytosis that retrieves
giant vesicles from the membrane. In agreement with the mul-
tiple types of exocytosis in MC, a recent electrophysiological
study has shown that, in addition to classical mode endocyto-
sis, kiss-and-run as well as compound exocytosis events can be
delineated (126).
Following exocytotic fusion the formed SNARE complexes are
also reconstituted into the individual SNARE proteins. This is
achieved by the NSF ATPase (127) and represents the energy
consuming step within the SNARE cycle (98). The necessity of
NSF in MC exocytotic event has been demonstrated by the fact
that transfection of an inactive NSF mutant into RBL MC blocks
degranulation (63).
DE NOVO SECRETORY PATHWAYS
Besides secreting mediators prestored in cytoplasmic granules, MC
release also a whole array of de novo synthesized mediators. These
include lipid compounds such as leukotrienes and prostaglandins,
which are generated from arachidonic acid released from nuclear
membrane phospholipids through the action of cytosolic phos-
pholipase A2. These compounds are synthesized in the cytosol
and then diffuse across the PM due to their lipid-derived nature
and hence do not require lipid transport mechanisms (128).
MC also synthesize and release a large set of different cytokines,
growth factors, and chemokines. An extensive list produced by MC
can be found in a review by Galli and coworkers (4). Contrary
to the lipid mediators, they are proteins and synthesized at the
rough ER and released along the secretory pathway using vesicular
carriers (31). As indicated certain cytokines and growth factors
such as TNF and VEGF have also been shown to be present in
cytoplasmic granules and thus can also be released by anaphylac-
tic degranulation providing an immediate source available within
minutes (4, 42). On the contrary de novo synthesized cytokines
and chemokines require several hours to obtain maximal levels of
secretion engaging complex signaling pathways. They involve tran-
scriptional regulation through transcription factors, epigenetic
control mechanisms, as well as post-transcriptional regulation
through mRNA stabilization and microRNA (miRNA). Signaling
pathways also exist at the level of vesicular trafficking regulating
the selective sorting to specific small vesicles and tubovesicular
organelles. The relative contribution of these control mechanisms
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FIGURE 4 | Late signaling events in de novo cytokine/chemokine
production. Stimulation of different membrane receptors lead to the
activation of transcription factors, modulators of mRNA turnover, and
effectors of ribosome activity that provoke long-lasting secretion of
lymphokines in mast cells. After FcεRI triggering with IgE/antigen (Ag)
complexes, Lyn and Fyn tyrosine kinases become activated and
phosphorylate ITAMs from β and γ chains of the receptor. Further activation
of Syk kinase leads to the phosphorylation of a number of adapters (such as
LAT and NTAL) and enzymes (such as BTK and PLCγ). Enzymes and
adapters form different macromolecular aggregates leading to the activation
of different signaling pathways. PLCγ activation is connected with
PKCα/β-dependent events through the generation of DAG and IP3. PKCα/β
connect FcεRI triggering with IKK activation and IκB degradation, leading to
nuclear translocation of NFκB. IP3-sensitive calcium release from
intracellular stores lead to the activation of a store-operated Ca2+ entry
(SOCE). IgE/Ag stimulation initiates also a receptor-operated Ca2+ entry
(ROCE). Calcium increase allows calcineurin-dependent dephosphorylation
and nuclear translocation of NFAT. On the other hand, Fyn-PI3K pathway
leads to the activation of IKK and NFκB-dependent transcription but also
triggers AKT, which controls mTor kinase and the initiation of protein
translation by S6K and 4E-BP1. Activation of MAPK provokes the activation
of AP-1 transcription factor but also modifies cytokine mRNA turnover
through the modulation of mRNA-binding proteins such as HUR and
Tristetraprolin (TTP). Binding of monomeric IgE to FcεRI induces
mTor-dependent changes on 4E-BP1 phosphorylation leading to
modifications on cap-dependent protein translation. Stimulation of toll-like
receptor 4 (TLR4) leads to NFκB-mediated transcription by the
MyD88/Mal-dependent pathway, which renders IKK activation after the
TRAF-6/TAK1 axis. IKK, either activated by FcεRI or TLR4 receptors,
phosphorylates SNAP-23 facilitating secretion. Also, IKK triggering (together
with some calcium-dependent signals) modulates HIF1-α-dependent
transcription. Once translated, cytokines and angiogenic factors are
secreted for variable periods of time utilizing specific vesicle carriers. See
text for details.
remains to be clarified but could largely differ between individ-
ual cytokines and chemokines. Some of the important signaling
steps leading to their secretion are summarized in the following
chapters.
TRANSCRIPTIONAL CONTROL BY THE ACTIVATION OF TRANSCRIPTION
FACTORS
Figure 4 displays some of the important signaling pathways con-
trolling de novo synthesis of cytokines in MC. Some of the details
of the early signaling events leading to the activation of Ca2+
mobilization and PKC via PLCγ and DAG have already been
described above. This PLCγ-DAG-Ca2+ signaling then initiates a
signaling wave that culminates in the activation of different tran-
scription factors for cytokine/chemokine production. Important
transcription factors include nuclear factor of activated T cells
(NFAT), nuclear factor-kappa B (NFκ-B), and activator protein-1
(AP-1), but many other transcription factors may also be involved
depending on the cytokine/chemokine gene.
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Nuclear factor of activated T cells are a family of four
transcription factors (NFAT1–4) that in normal conditions are
phosphorylated and reside in the cytoplasm (129). MCs have been
shown to express NFAT1 and 2 (130). In stimulated cells, NFAT
becomes dephosphorylated by calcineurin, a Ca2+-calmodulin-
dependent serine/threonine phosphatase. This results in a confor-
mational change that now exposes a nuclear localization sequence
(NLS), which binds importins, allowing NFAT translocation to
the nucleus and initiation of the transcription of a number of pro-
inflammatory and regulatory cytokine genes, such as IL-2, IL-4,
IL-13, and TNF (130, 131). The rephosphorylation of NFAT then
exposes a nuclear export sequence (NES) enabling transport back
into the cytosol via the exportin Crm1.
Another essential transcription factor regulating cytokine
expression in MC is NFκB (132). This family of proteins includes
five members: NFκB1 (p50), NFκB (p52), RelA (p65), RelB, and
cRel. Although they can form different homo and heterodimers,
p50/cRel is the most common form of NFκB in immune cells
(133). In MC, as in other immune cells, the activity of NFκB is
controlled by inhibitor of kappa B (IκB) protein that binds to the
heterodimer in the cytoplasm maintaining it in an inactive confor-
mation. Activation of NFκB occurs when the IKK phosphorylates
IκB on serine residues to target it to proteasomal degradation after
polyubiquitination (133). FcεRI-dependent activation of NFκB
in MC depends on the activation and lipid raft recruitment of the
classical isoform of PKCβ (134) and on the formation of a complex
formed by B cell lymphoma 10 (Bcl10) and mucosal-associated
lymphoid tissue 1 (Malt1) (135). The PKCβ–Bcl10–Malt1 complex
is necessary for NFκB activation and cytokine gene transcription,
but not for secretion of pre-formed mediators in MC. Bcl10- and
Malt1-deficient MC show normal MAPK (p38, ERK, and JNK),
PKC and Akt activation after FcεRI crosslinking but IKK-induced
phosphorylation of IκBα and its degradation is completely blocked
(135). NFκB is essential for the synthesis of an important number
of cytokines in MC including TNF and IL-6 (136).
Besides binding PKC DAG also binds to RAS-guanyl
nucleotide-releasing protein (Ras-GRP). Together they activate
MAPK and IKK, leading to the activation of the AP-1 (Fos-Jun)
and nuclear factor κB (NFκB) transcription factors, respectively
(137, 138). AP-1 consists of homo- and hetero-dimers of Jun fam-
ily proteins, as well as heterodimers of Fos an Jun (139). Fos and
Jun proteins are also synthesized and activated by phosphorylation
(140). AP-1 acts together with NFAT and NFκB for synergistic acti-
vation of cytokine genes (129) for example after costimulation of
MC with antigen and IL-33 (141).
Interestingly, NFAT, AP-1, and NFκB are optimally activated
in response to different patterns of Ca2+ signaling in T cells.
Transient high Ca2+ spikes lead to sustained activation of JNK
and NFκB, but not NFAT, whereas, prolonged low increases in
[Ca2+]i, were sufficient to activate NFAT (142). Furthermore, as
already mentioned above release characteristics depends on the
strength of stimulus and this also holds true the activation of
NFAT in MC (143).
POST-TRANSCRIPTIONAL CONTROL OF CYTOKINE PRODUCTION
Post-transcriptional regulatory mechanisms play an important
role in the regulation of cytokine gene expression (144). They
depend in part on specific mRNA sequences present in the 3′
untranslated region (3′ UTR). One major class consists of a
conserved AU-rich sequence element (ARE) composed of several
repeats of the pentanucleotide AUUUA present in mRNAs encod-
ing growth factors, oncoproteins, or cytokines (145). The ARE has
been associated with both an accelerated degradation of mRNA
and interference with translation (146). Investigations in mice
lacking the TNF ARE sequence in the mouse genome have clearly
shown that the TNF ARE was required both for the alleviation and
reinforcement of message destabilization and translational silenc-
ing in stimulated cells. Moreover, the mutant mRNA was no longer
responsive to translational modulation by p38 and JNK kinases,
demonstrating that the TNF ARE is a target for these signals (147).
One major regulator in this mechanism is TTP, the prototype of a
CCCH-zinc finger proteins able to bind to the ARE and to interact
with a number of proteins able to regulate mRNA stability and
translational control (148). In unstimulated cells, TTP associates
with factors that mediate translational repression and mRNA
decay, while in stimulated cells with high p38-mitogen-activated
protein kinase (p38) and the c-Jun N-terminal/stress-activated
protein kinase (JNK/SAPK) activity it associates with proteins that
enhance mRNA stability and translation (148).
Cytokine synthesis is also controlled at the level of translation
initiation (149). The key signaling pathway controlling the ini-
tiation of translation in eukaryotic cells has been shown to be
commanded by the mTOR kinase (150) related to lipid kinases
and an essential component of two distinct multiprotein com-
plexes named mTOR complex 1 (mTORC1) and mTOR complex
2 (mTORC2) (150). mTORC1, the rapamycin-sensitive complex,
consists of mTOR, raptor, and LST8. The mTORC1 signals to
inhibitory 4E-binding protein-1 (4EBP-1) and 40S ribosomal pro-
tein S6 kinase (S6K), which mediates efficient cap-dependent
translation initiation (151). PI3K regulates the mTORC1 path-
way via the activation of AKT (151). In MC, IgE-Ag stimulation
induces PI3K-dependent activation of mTORC1, S6K1, and 4E-
BP1 (52). Inhibition of mTORC1 with rapamycin had no effect on
degranulation but inhibited IgE/Antigen-induced IL-6 and IL-8
production and MC survival (52). Interestingly, rapamycin also
provoked the destabilization of TNF mRNA in a process that
required the TNF ARE in RBL-2H3 cells (152).
Besides cap-dependent translation, mRNAs for some angio-
genic mediators, such as the VEGF, can be translated from a
structured RNA element termed an internal ribosomal entry site
(IRES) able to recruit the 40S ribosomal subunit (153). It has
been found that in response to hypoxia and some other stim-
uli, 4E-BP1 and eIF4G participate in a regulatory pathway that
switch protein translation from the normal cap-dependent to the
IRES-dependent process (154) allowing selective protein synthe-
sis to cope with an adverse environment. In MC, monomeric IgE
induces the release of VEGF from a pre-formed pool but also
importantly induces the production of VEGF mRNA by the long-
lasting secretion of newly synthesized protein (155). IgE addition
to BMMCs leads to dephosphorylation of 4E-BP1, indicating that
low-level stimulation of FcεRI is able to induce IRES-dependent
translation. The translational switch triggered by IgE was depen-
dent on Fyn kinase activation and correlated with an increase in
VEGF mRNA accumulation and VEGF secretion (156).
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microRNAs AND CYTOKINE PRODUCTION IN MC
microRNAs are a large class of endogenous single-stranded small
non-coding RNA molecules that control gene expression by bind-
ing to the 3′ untranslated region (3′ UTR) of mRNAs thereby
reducing protein synthesis through repression of translation or
induction of mRNA degradation. miRNAs control maturation,
proliferation, migration, and activation of immune cells (157).
MCs express a number of different miRNAs implicated in pro-
duction of pro-inflammatory mediators. For example, miR-221,
originally described to regulate the cell cycle of MC, was shown
to favor MC adhesion and migration toward SCF or antigen. This
improved IgE/Ag-mediated degranulation and IL-6 and TNF pro-
duction (158). The miR-146a was found to negatively regulate
NFκB signaling, blunting the elevated cytokine production after
bacterial infections (159) and contributing to endotoxin toler-
ance. In MC, miR-146a expression in response to different stimuli
is dependent on NFκB p50 (160). MiR-155 expression enhanced
FcεRI degranulation and release of TNF, IL-6, and IL-13 related
to the activity of the PI3K/Akt pathway (161). Recently, a sys-
tematic analysis of miRNA expression during the differentiation
of BMMCs lead to the identification of 11 miRNAs that regulate
the expression of specific transcription factors and 13 miRNAs
that target transcripts of mMCP4 and mMCP6, regulating the
synthesis of pre-formed inflammatory mediators (162).
EPIGENETIC CONTROL OF CYTOKINE PRODUCTION IN MC
Epigenetic modifications have been shown to influence the syn-
thesis of transcription factors and to modify the sensitivity of
promoters including in MC (163). For example, in vitro MC differ-
entiation of MC was associated with decreased CD34 expression
and increased HIF1A expression compared with bone marrow
precursors. These changes were paralleled with changes in the
methylation status of the promoters of those genes, suggesting
that DNA methylation-dependent epigenetic regulation mediates
the gene expression changes involved in maintaining the phe-
notype of mature MCs together with the differentiation of the
HMC-1 cell line (164, 165). In another study, two constitutively
DNAse I hypersensitivity sites (HSs) were described within the
first intron of the IL-13 gene present in MC regulating the acces-
sibility of the IL-13 locus for high level transcription (166). In
the murine MC line derived from fetal liver CFTL-15, a cis-acting
element in the second intron of the murine IL-4 gene has a dual
function in regulating transcription in MC as well as chromatin
accessibility of the IL-4 gene locus through the influence on the
methylation state of the gene. MC-restricted transcription factors
GATA-1/2 and PU.1 associate with the intron element and regulate
its activity (167, 168).
Epigentic modifications are involved not only in the increase on
gene transcription but also in the long-term inhibition of cytokine
synthesis. In the THP-1 promonocytic cell line, during endotoxin
tolerance, it was found that transcription of TNF gene in normal
cells was preceded by dissociation of heterochromatin-binding
protein 1α, demethylation of nucleosomal histone H3 lysine 9
increased phosphorylation of the adjacent serine 10, and recruit-
ment of NFκB RelA/p65 to the TNF gene promoter. This was no
more observed in tolerant cells and RelB, a repressor of transcrip-
tion, remained bound to the promoter during silencing (169).
Since MCs become tolerant after prolonged exposure to LPS, it is
possible to speculate that the mentioned mechanisms of TNF gene
silencing could also apply.
MOLECULAR TRAFFICKING EVENTS IN CYTOKINE/CHEMOKINE
SECRETION
Contrary to the considerable advances made in the understand-
ing of the regulation of fusion during anaphylactic degranulation,
little is still known about the vesicular trafficking involved in MC
cytokine/chemokine secretion. One problem is that endogenous
cytokines and chemokines are not easily traceable for imaging
studies due to the fact that they are secreted over a period of several
hours. Thus, for example in macrophages one can observe protein
accumulating in the Golgi, while vesicular structures are more dif-
ficult to delineate (170). Yet, Stow and coworkers have succeeded
to image TNF secretory vesicles in macrophages, which produce
considerable amounts of TNF that can be further enhanced by
costimulating cells with IFNγ (171). Furthermore, in the case
of TNF, addition of a TNF converting enzyme (TACE) inhibitor
allows to block cleavage of transmembrane TNF at the PM and
to detect its accumulation in the cell surface or in endocytosed
vesicular structures (172). In some cases, the authors have also
used overexpressed fluorescently tagged cytokines (TNF or IL-6)
(173). Interestingly, while continuously produced from the viral
promoter, their protein expression further increases after stimula-
tion, which may in part be due to the fact that stimulation leads to
enhancement of posttranslational control and vesicular trafficking
mechanisms.
Accumulated data suggest that chemokine/cytokine secretion
does not follow a unique trafficking pathway but rather could
involve multiple pathways and organelles depending also whether
they get delivered locally, such as for example at the T cell synapse
(174) or the phagocytic cup in macrophages (31) or whether the
release is more multidirectional on the cell surface. However, all
studies agree that cytokine trafficking differs from the secretion
of cytoplasmic SGs containing prestored mediators such as for
example shown in NK cells (175).
Most of the vesicular trafficking events have been studied in
macrophages. Here, after the initial transport through the Golgi
stacks, TNF and IL-6 were found to bud off in highly dynamic
tubular–vesicular structures (173). Interestingly, while TNF was
generally found together with IL-6, the majority of IL-6 was found
in independent carriers. All of them were finally delivered to the
ERC, but they seem to reside in distinct non-overlapping areas.
From the ERC, the individual cytokines are secreted independently
with TNF largely fusing locally at the phagocytic cup, while IL-6
is secreted independently and not targeted to the phagocytic cup.
This suggests that the ERC acts as a sorting hub for local secretion
of cytokines. Interestingly, examination of another cytokine, IL-
10, shows that only about half is delivered to the ERC, while the
other half takes another transport route where it is directly deliv-
ered from the TGN to the PM via vesicular carriers containing the
lipid binding protein ApoE (176). PMD has also been evoked as
another mechanism for cytokine secretion. This concerns mostly
cytokines prestored in cytoplasmic granules of eosinophils (177).
Concerning the SNARE fusion proteins necessary for consti-
tutive secretion it was found that stimulation of macrophages
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generally increases their expression, which could be a means
to enhance the cytokine trafficking (171, 178). Similarly, some
other regulatory proteins such as Rab and Munc18 isoforms are
upregulated in LPS-stimulated macrophages (178). The fusion of
vesicular carriers arriving from the TGN to the ERC seems to
imply a SNARE complex containing the t-SNAREs Syntaxin 6 and
Vti1b as well as the ERC-localized v-SNARE VAMP-3. The PM
delivery implies a complex composed of SNAP-23 and Syntaxin
4 as well as VAMP-3 (31). Initial analysis of signaling events dur-
ing such transport indicate that transport is not simply a default
mechanism but to the contrary highly regulated. In particular, LPS
allows recruitment of PI3Kδ to the TGN, where it allows recruit-
ment of the GTPase dynamin involved in the fission of budding
tubulovesicular structures (179). The phosphocholine cytidylyl-
transferase involved in lipid biogenesis seems also to get activated
during this process (31).
Only a few studies have addressed the vesicular trafficking
mechanisms in MC. Generally, they point to the fact that, with the
exception of cytokines stored in cytoplasmic granules released by
anaphylactic degranulation, they are released in a distinct manner
that could resemble the mechanisms worked out in macrophages.
Indeed, so far none of the SNARE accessory molecules involved in
anaphylactic degranulation has shown an implication in cytokine
trafficking. Neither the absence of Munc18-2 (70) nor of Syt
II (100) has impacted on the secretion of cytokines such as
TNF, IL-6, IL-4, or the chemokine CCL2 into the extracellu-
lar medium. The latter implies that calcium-mediated regulation
may not play a major role in cytokine trafficking although other
Syts expressed in MC (7) have not been tested. Yet, secretion of
cytokines/chemokines in MC clearly implies SNARE fusion pro-
teins. In human MC, it was shown that introduction of antibodies
directed against PM localized t-SNAREs SNAP-23, Syntaxin 3,
and Syntaxin 6 could block secretion in permeabilized human
MC of all chemokines tested (CCL2, CCL3, CCL4, and CXCL8)
albeit it was not always significant in the case of Syntaxin 6 (71).
Anti-Syntaxin 4 and anti-VAMP-8 were able to selectively inhibit
CXCL8, which could be explained by the fact that CXCL8 is
stored in significant amounts in cytoplasmic granules of human
MC and hence uses SNARE proteins involved in anaphylactic
degranulation of human MC (28). No effects were seen neither
for anti-Syntaxin 2, which localizes to the cytosol or the lysoso-
mal marker VAMP-7 (71). In murine MC, functional data with
SNARE proteins are not yet available, although the implication of
VAMP-3 is suggested by the strong colocalization of VAMP-3 con-
taining vesicles with TNF that had been protected against cleavage
by a TACE inhibitor, while no colocalization with VAMP-8 con-
taining vesicles was found (66, 180). This suggests that TNF may
in a similar manner to macrophages take route through the ERC.
Alternatively, it may also be delivered via the constitutive secretory
pathway. Further studies in MC are however necessary to delineate
the various vesicular trafficking events involved.
DISEASES ASSOCIATED WITH SG BIOGENESIS AND
VESICULAR TRAFFICKING AND MAST CELL PHENOTYPE
In addition to the fundamental studies examining the secretory
mechanisms of vesicular trafficking some important informa-
tion has also been obtained from the study of inherited diseases
in humans affecting SG biogenesis and secretory mechanisms
in immune cells. Due to the associated defects of lymphocyte
cytotoxic functions many of these diseases are characterized by
a pathological condition called hemophagocytic lymphohistiocy-
tosis (HLH) with defects in cytotoxic activity and expansion of
polyclonal CD8-positive T cells and IFNγ-activated phagocytic
macrophages, which infiltrate multiple organs and tissues includ-
ing the nervous system causing also neurological manifestations
[reviewed in Ref. (181)]. Amongst the familial forms of these dis-
eases one can find familial lymphohistiocytosis 1 (FLH1) the most
frequent form (50%) with still unknown genotype, FLH2 with a
defect in the cytotoxic granule protein perforin, FLH3 with a defect
in the SNARE accessory protein Munc13-4, FLH4 with a defect
in the t-SNARE syntaxin 11, FLH5 with a defect in the SNARE
accessory protein STXBP2 (Munc18-2) (181). Additional diseases
showing signs of HLH include Griscelli Syndrome 2 (GS2) with a
defect in Rab27A, Chediak–Higashi syndrome characterized by the
presence of giant secretory lysosomes and a defect in the Lysosomal
trafficking regulator (Lyst ) gene (181). Another disease complex
with secretory phenotypes is the Hermansky–Pudlak syndrome a
heterogenous conditions leading to with different types of muta-
tions in genes (HPS1, AP3B1, HPS3, HPS4, HPS5, HPS6, DTNBP1,
BLOC1S3, and BlOC1S6) (182). Except for AP3B1 their protein
products are part of the Biogenesis of Lysosome-related Organelles
Complexes (BLOC), which regulates the traffic of vesicles in the
endosomal system and also participate in endosomal membrane
secretory lysosome fusion. Clinically the diseases are character-
ized by platelet secretory dysfunctions with altered granules and
oculocutaneous albinism, pulmonary fibrosis, and granulomatous
colitis (182). However, only defects in AP3B1, which is part of the
AP-3 adaptor complex involved in the formation of new vesicles
at the Golgi complex is also associated with lymphohistiocytosis
and immune deficiency.
While the MCs phenotype has not been studied in human dis-
eases some knowledge has been obtained from MCs obtained from
mice carrying equivalent mutations. We have already described
the effect of Munc13-4, Syntaxin 11, Munc18-2, and Rab27 muta-
tions, which except for Syntaxin 11 all show a secretory phenotype.
However, this generally concerns only anaphylactic degranulation,
while for example cytokine/chemokine production seems not to be
affected for example in Munc18-2 deficient cells (see above). Some
earlier studies have also analyzed the effect of LYST mutations in
MCs obtained from the beige mouse model. LYST codes for a
ubiquitously expressed huge (425 kDa) cytosolic protein belong-
ing to the BEACH (beige and Chediak–Higashi) family of proteins,
which are proteins involved in vesicular trafficking and synap-
tic transmission, although their exact function is still unknown.
Interestingly, LYST interaction partners include proteins involved,
which are part of the ESCRT complex, suggesting a role of Lyst in
the formation of intraluminal vesicles. Alternatively, data from the
beige mouse model with a defect in LYST or LYST overexpression
data indicate that LYST could be important in vesicle generation by
fission (183). Indeed, MCs obtained from beige mouse are charac-
terized largely increased giant granules (about 18× the volume),
while granules of pancreatic acinar cells showed only a minor
increase (23%) (184), suggesting that this may apply specifically to
secretory lysosomes as granules from other hematopoietic cells are
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also increased (183). Furthermore, granule composition appeared
to be normal (185). Functional studies also showed that beige
MCs were degranulation competent but seemed to show a higher
frequency of granule–granule fusion events (186). Electrophysio-
logical studies showed that membrane capacitance increases were
about 10-fold higher in beige MCs in agreement with the large
granule size (118).
Concerning Hermansky–Pudlak syndrome (HPS) only one
elecrophysiological study has been performed with MCs from the
ruby-eye mouse showing a defect in HPS6. HSP6 is part of the
BLOC-2 complex composed of HSP3, HSP5, and HSP6. Patients
with defects in BLOC-2 show a somewhat milder phenotype
with absence of the development of pulmonary fibrosis. It inter-
acts with BLOC-1 (DTNBP1, BLOC1S3, and BlOC1S6) required
for cargo-specific sorting from early endosomes to lysosome-
related organelles (187). In MCs derived from the ruby-eye mouse
model a fusion pore phenotype was observed in electrophys-
iological studies with a threefold increase in the fraction and
duration of transient fusion events (188). This suggests that
HPS6 and potentially BLOC-2 may also play a direct role in
secretion. The increased number of transient fusion events may
also be an explanation for the observed platelet granule storage
deficiency.
CONCLUDING REMARKS
The secretion of inflammatory mediators by MC through vesicular
carriers is a highly regulated process starting with the biogen-
esis of SGs. Release is triggered by the activation of cell sur-
face receptors initiating signaling processes culminating in the
release from cytoplasmic granules by anaphylactic degranula-
tion. As shown in this review many new signaling effectors have
been described regulating the various steps involved in SG bio-
genesis and secretion. De novo production of cytokine requires
additional control mechanisms at the level of transcriptional and
post-transcriptional control of protein synthesis but as new data
show may also be regulated at the level of vesicular trafficking,
differing from the ones involved in the control of anaphylactic
degranulation.
In addition, evidence has shown that MCs are receptive to a
number of outside agents activating signaling pathways able to
modulate the capacity of MC for secretion. These include, for
example immunosuppressive cytokines like the members of the IL-
10 family and the TGF-β superfamily (TGFβ and activins) (189).
Certain Fc receptors have been also shown to negatively control
signaling responses induced by MC (190, 191). Certain GPCRs
coupled to Gs proteins that induce the production of cyclic AMP
(such as β2-adrenergic, A2, and PGE2 receptors), (192) or opi-
ates acting through δ- or µ opiate receptors can also be potent
inhibitors of MC secretion (193).
Together, this shows the necessity for exquisite control of
the MC secretory processes in order to avoid the dangerous
consequences it may have.
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